Interphase FISH in plasma cell dyscrasia: increase in abnormality detection with plasma cell enrichment

被引:10
|
作者
Pozdnyakova, Olga [1 ]
Crowley-Larsen, Patricia [2 ]
Zota, Victor [1 ]
Wang, Sa A. [3 ]
Miron, Patricia A. [1 ,2 ]
机构
[1] UMass Mem Med Ctr, Dept Pathol, Worcester, MA 01605 USA
[2] UMass Mem Med Ctr, Dept Hosp Labs, Worcester, MA 01605 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
IN-SITU HYBRIDIZATION; MULTIPLE-MYELOMA; UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; CYTOGENETICS; INSIGHTS;
D O I
10.1016/j.cancergencyto.2008.11.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Historically, cytogenetic studies of plasma cell neoplasms have been hampered by the fact that terminally differentiated plasma cells do not proliferate well in vitro. Although the use of interphase FISH (iFISH) has greatly improved the ability to detect cytogenetic abnormalities, cases with low numbers of neoplastic cells often do not demonstrate abnormalities. Using a four-assay, nine-probe iFISH panel, we compared the abnormality detection rate for overnight unstimulated bone marrow cultures (ONC) to that for plasma-cell enriched fractions obtained with use of CD138-coated immunomagnetic beads (PCE). In the ONC, an abnormality was detected in I I of 29 cases (38%); in the PCE, an abnormality was detected in 30 of 33 cases (91%). For 28 cases in which iFISH results from ONC were compared directly with PCE samples, the overall abnormality rate was 36% for ONC and 89% for PCE (P < 0.01). The conventional GTG-banded chromosome analysis revealed only 2 of 34 cases with an abnormal karyotype (6%); both cases were hyperdiploid. We conclude that the plasma cell enrichment step for iFISH should be incorporated into the routine cytogenetic work-up for all patients with plasma cell neoplasms. (C) 2009 Elsevier Inc. All fights reserved.
引用
收藏
页码:112 / 117
页数:6
相关论文
共 50 条
  • [1] Interphase Fluorescence In Situ Hybridization on Selected Plasma Cells is Superior in the Detection of Cytogenetic Aberrations in Plasma Cell Dyscrasia
    Put, Natalie
    Lemmens, Heidi
    Wlodarska, Iwona
    Konings, Peter
    Moreau, Yves
    Hagemeijer, Anne
    Vandenberghe, Peter
    Michaux, Lucienne
    GENES CHROMOSOMES & CANCER, 2010, 49 (11) : 991 - 997
  • [2] Coexistence of Myeloproliferative Neoplasm and Plasma-Cell Dyscrasia
    Malhotra, Jyoti
    Kremyanskaya, Marina
    Schorr, Emily
    Hoffman, Ronald
    Mascarenhas, John
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (01) : 31 - 36
  • [3] Hematopoietic Cell and Renal Transplantation in Plasma Cell Dyscrasia Patients
    Baraldi, Olga
    Grandinetti, Valeria
    Donati, Gabriele
    Comai, Giorgia
    Battaglino, Giuseppe
    Cuna, Vania
    Capelli, Irene
    Sala, Elisa
    La Manna, Gaetano
    CELL TRANSPLANTATION, 2016, 25 (06) : 995 - 1005
  • [4] TEMPI Syndrome: Erythrocytosis in Plasma Cell Dyscrasia
    Zhang, Xianrui
    Fang, Meiyun
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (11) : 724 - 730
  • [5] Plasma Cell Dyscrasia of the Calcaneus A Rare and Unusual Case Presentation
    Ly, Peter N.
    JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2021, 111 (03)
  • [6] Plasma Cell Enrichment Enhances Detection of High-Risk Cytogenomic Abnormalities by Fluorescence In Situ Hybridization and Improves Risk Stratification of Patients With Plasma Cell Neoplasms
    Lu, Gary
    Muddasani, Ramya
    Orlowski, Robert Z.
    Abruzzo, Lynne V.
    Qazilbash, Muzaffar H.
    You, M. James
    Wang, Yaping
    Zhao, Ming
    Chen, Su
    Glitza, Isabella Claudia
    Medeiros, L. Jeffrey
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (05) : 625 - 631
  • [7] Superior detection rate of plasma cell FISH using FACS-FISH
    Gagnon, Marie-France
    Midthun, Sally M.
    Fangel, James A.
    Schuh, Cynthia M.
    Luoma, Ivy M.
    Pearce, Kathryn E.
    Meyer, Reid G.
    Ailawadhi, Sikander
    Arribas, Mariano J.
    Braggio, Esteban
    Fonseca, Rafael
    Rajkumar, S. Vincent
    Zepeda-Mendoza, Cinthya
    Xu, Xinjie
    Greipp, Patricia T.
    Timm, Michael M.
    Otteson, Gregory E.
    Shi, Min
    Jevremovic, Dragan
    Olteanu, Horatiu
    Peterson, Jess F.
    Ketterling, Rhett P.
    Kumar, Shaji
    Baughn, Linda B.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 161 (01) : 60 - 70
  • [8] Normolipemic Xanthomas in a Patient with Underlying Plasma Cell Dyscrasia
    Devin Malik
    Sukhpreet Singh
    Akshay Amaraneni
    Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 745 - 746
  • [9] Target fluorescence in-situ hybridization (Target FISH) for plasma cell enrichment in myeloma
    Ma, Edmond S. K.
    Wang, Candy L. N.
    Wong, Anthony T. C.
    Choy, Gigi
    Chan, Tsun Leung
    MOLECULAR CYTOGENETICS, 2016, 9
  • [10] Multicolor interphase cytogenetics for the study of plasma cell dyscrasias
    Saez, Borja
    Martin-Subero, Jose I.
    Odero, Maria D.
    Prosper, Felipe
    Cigudosa, Juan C.
    Schoch, Robert
    Calasanz, Maria J.
    Siebert, Reiner
    ONCOLOGY REPORTS, 2007, 18 (05) : 1099 - 1106